Want to see ENGN full AI Analyst Report?
enGene Holdings (ENGN) Stock Statistics & Valuation Metrics
Total Valuation
enGene Holdings has a market cap or net worth of $102.53M. The enterprise value is -$108.30M.
- Market Cap
- $102.53M
- Enterprise Value
- -$108.30M
Share Statistics
enGene Holdings has 67,016,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 67,016,320
- Owned by Insiders
- 4.47%
- Owned by Institutions
- 1.65%
Financial Efficiency
enGene Holdings’s return on equity (ROE) is -0.70 and return on invested capital (ROIC) is -61.74%.
- Return on Equity (ROE)
- -0.70
- Return on Assets (ROA)
- -0.53
- Return on Invested Capital (ROIC)
- -61.74%
- Return on Capital Employed (ROCE)
- -0.65
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.43M
- Employee Count
- 82
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of enGene Holdings is -5.46. enGene Holdings’s PEG ratio is -0.05.
- PE Ratio
- -5.46
- PS Ratio
- 0.00
- PB Ratio
- 0.46
- Price to FCF
- -0.99
- Price to Operating Cash Flow
- -1.03
- PEG Ratio
- -0.05
Income Statement
In the last 12 months, enGene Holdings had revenue of 0 and earned -117.30M in profits. Earnings per share was -2.29.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -123.17M
- Pretax Income
- -117.30M
- Net Income
- -117.30M
- EBITDA
- -113.80M
- Earnings Per Share (EPS)
- -2.29
Cash Flow
In the last 12 months, operating cash flow was -103.31M and capital expenditures -688,000, giving a free cash flow of -104.00M billion.
- Operating Cash Flow
- -103.31M
- Free Cash Flow
- -104.00M
- Free Cash Flow per Share
- -1.49
Dividends & Yields
enGene Holdings pays an annual dividend of $0.13, resulting in a dividend yield of ―
- Dividend Per Share
- $0.13
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -101.43%
- Earnings Yield
- -4.60%
Stock Price Statistics
- Beta
- 0.44
- 52-Week Price Change
- -78.02%
- 50-Day Moving Average
- 1.80
- 200-Day Moving Average
- 4.32
- Relative Strength Index (RSI)
- 37.12
- Average Volume (3m)
- 757.53K
Important Dates
enGene Holdings upcoming earnings date is Dec 23, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 08, 2026
- Next Earnings Date
- Dec 23, 2026
- Ex-Dividend Date
- Feb 02, 2015
Financial Position
enGene Holdings as a current ratio of 6.30, with Debt / Equity ratio of 18.96%
- Current Ratio
- 6.30
- Quick Ratio
- 6.30
- Debt to Market Cap
- 0.07
- Net Debt to EBITDA
- 0.16
- Interest Coverage Ratio
- -41.14
Taxes
In the past 12 months, enGene Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
enGene Holdings EV to EBITDA ratio is -0.72, with an EV/FCF ratio of -0.91.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.72
- EV to Free Cash Flow
- -0.91
- EV to Operating Cash Flow
- -0.92
Balance Sheet
enGene Holdings has $266.32M in cash and marketable securities with $33.27M in debt, giving a net cash position of $233.05M billion.
- Cash & Marketable Securities
- $266.32M
- Total Debt
- $33.27M
- Net Cash
- $233.05M
- Net Cash Per Share
- $3.48
- Tangible Book Value Per Share
- $3.30
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for enGene Holdings is $2.80, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $2.80
- Price Target Upside
- 83.01% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 6
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -9.75%
Scores
- Smart Score
- 2
- AI Score
- 52